InvestorsHub Logo
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Re: Investor100 post# 51087

Saturday, 02/25/2012 7:50:23 PM

Saturday, February 25, 2012 7:50:23 PM

Post# of 97239
OT: FDA Panel Calendar

Stocks that have PDUFA decisions in March and one key stock with advisory committee meeting!

Date:02/26/2012
Company:Columbia Laboratories, Inc.
Ticker:CBRX
Drug:PROCHIEVE
Event:PDUFA 2/26/12 of PROCHIEVE for reduction of risk of preterm birth.

Date:03/06/2012
Company:Astex Pharmaceuticals, Inc.
Ticker:ASTX
Drug:Dacogen
Event:PDUFA 3/6/12 of sNDA of Dacogen for Acute myeloid leukemia (AML)


Date:03/06/2012
Company:Discovery Laboratories, Inc.
Ticker:DSCO
Drug:Surfaxin
Event:PDUFA 3/6/12 of Surfaxin for Respiratory Distress Syndrome


Date: 03/07/2012

Company:NeurogesX, Inc.
Ticker:NGSX
Drug:Qutenza
Event:PDUFA 3/7/12 of Qutenza for Neuropathic pain associated with HIV-associated peripheral neuropathy (HIV-PN)


Date:03/21/2012
Company:TALON THERAPEUTICS
Ticker:TLON
Drug:Marqibo
Event:Advisory Committee Meeting March 21, 2012 for Marqibo in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

Date:03/26/2012

Company:MAP Pharmaceuticals, Inc.
Ticker:MAPP
Drug:Levadex
Event:PDUFA 3/26/12 of LEVADEX for Migraine


Date:03/27/2012
Company:Affymax, Inc.
Ticker:AFFY
Drug:Peginestide
Event:PDUFA 3/27/2012 of Peginesatide for Anemia in chronic renal failure (CRF)

Date:03/28/2012
Company:Chelsea Therapeutics Internatio
Ticker:CHTP
Drug:Northera
Event:PDUFA 3/28/2012 of Northera for Neurogenic Orthostatic Hypotension

Investor 100

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.